SCHEMBL20458565

SCHEMBL20458565

N#Cc1cc(-c2cccnc2)c(C2CC2)nc1N1CCNCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.44
CYP3A4 P08684 5/20 0.44
CYP2D6 P10635 3/20 0.44
GBA1 P04062 1/20 0.44
ALOX15 P16050 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
KDM4E B2RXH2 2/20 0.43
PIM1 P11309 2/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
TAAR1 Q96RJ0 1/20 0.40
LMNA P02545 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGDS O60760 1/20 0.39
CYP11B2 P19099 3/20 0.39
LRRK2 Q5S007 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14250208 0.86 CHRNB2 (0.37) HPGDSCYP11B2LRRK2CYP11B1
SCHEMBL14318169 0.86 CHRNB2 (0.37) HPGDSCYP11B2LRRK2CYP11B1
SCHEMBL20458563 0.78 IDH1 (0.39) CYP1A2CYP3A4CYP2D6HSD17B10CYP11B2
SCHEMBL15906804 0.75 TAAR1 (0.48) CYP1A2CYP3A4KDM4ETAAR1LMNA
SCHEMBL14251565 0.74 IDH1 (0.43)
SCHEMBL14315321 0.74 IDH1 (0.43)
SCHEMBL14251107 0.74 RET (0.44) GBA1
SCHEMBL20458564 0.74 RET (0.44) GBA1
SCHEMBL14060115 0.72 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6GBA1ALOX15
SCHEMBL7291236 0.71 CYP1A2 (0.54) CYP1A2CYP3A4CYP2D6ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2721019-B1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS INC (US) 2018-08-08 EP disclosed